Daniel Arber to Consensus
This is a "connection" page, showing publications Daniel Arber has written about Consensus.
Connection Strength
0.780
-
The International Consensus Classification of acute myeloid leukemia. Virchows Arch. 2023 Jan; 482(1):27-37.
Score: 0.171
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022 09 15; 140(11):1200-1228.
Score: 0.170
-
Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach. Am J Hematol. 2022 05; 97(5):514-518.
Score: 0.163
-
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort. Blood Cancer J. 2025 May 07; 15(1):88.
Score: 0.051
-
Evolution of WHO diagnostic criteria in "Classical Myeloproliferative Neoplasms" compared with the International Consensus Classification. Blood Cancer J. 2025 Mar 04; 15(1):31.
Score: 0.050
-
The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol. 2023 08; 98(8):1286-1306.
Score: 0.045
-
The International Consensus Classification of acute leukemias of ambiguous lineage. Blood. 2023 05 04; 141(18):2275-2277.
Score: 0.044
-
International Consensus Classification for myeloid neoplasms at-a-glance. Am J Hematol. 2023 01; 98(1):6-10.
Score: 0.043
-
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms. Am J Hematol. 2023 01; 98(1):166-179.
Score: 0.043